TNNI3 and myocardial infarction: PATHFAST cTnI-II is a Food and Drug Administration (FDA)-cleared high sensitivity point-of-care troponin assay that has demonstrated similar diagnostic performance for myocardial infarction against a central laboratory high sensitivity assay [16,26,27].